Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Joint ( (JYNT) ) is now available.
On May 8, 2025, The Joint Corp. reported its financial results for the first quarter of 2025, showing a 7% increase in revenue from continuing operations to $13.1 million compared to the same period in 2024. Despite a net loss from continuing operations of $506,000, the company demonstrated economic resilience with a 5% increase in system-wide sales to $132.6 million. The company is undergoing a transition to become a pure-play franchisor, implementing new marketing and operational strategies to enhance growth and profitability. The Joint Corp. expects system-wide sales to reach between $550 million and $570 million in 2025, with new franchised clinic openings projected between 30 and 40.
Spark’s Take on JYNT Stock
According to Spark, TipRanks’ AI Analyst, JYNT is a Neutral.
Joint Corp.’s stock reflects moderate performance with notable revenue growth and strategic refranchising efforts. However, profitability challenges, economic headwinds, and bearish technical indicators weigh down the score. The company’s focus on improving EBITDA through executive incentives and refranchising could enhance future performance.
To see Spark’s full report on JYNT stock, click here.
More about Joint
The Joint Corp. is a national operator, manager, and franchisor of chiropractic clinics, focusing on providing chiropractic care services across the United States.
Average Trading Volume: 65,938
Technical Sentiment Signal: Sell
Current Market Cap: $150.9M
For a thorough assessment of JYNT stock, go to TipRanks’ Stock Analysis page.